Canakinumab for the Treatment of Postprandial Hypoglycemia
Clinical trial NCT05401578 · RECRUITING
Trial details
- NCT number
- NCT05401578
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-17
- Primary completion
- 2026-05-31
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.